McKesson Corporation $MCK Position Trimmed by Employees Retirement System of Texas

Key Points

• Employees Retirement System of Texas trimmed its stake in McKesson by 6.3% in Q3, selling 4,632 shares and leaving 69,217 shares valued at about $53.47 million.
• McKesson beat quarterly expectations, reporting $9.34 EPS versus $9.19 expected and $106.16 billion in revenue (+11.4% YoY), and set FY2026 EPS guidance of 38.800–39.200.
• Insiders have been net sellers (3,868 shares worth ~$3.74M in the last 90 days) while institutional investors own 85.07% of the stock; the company also declared a $0.82 quarterly dividend (0.3% yield).

Employees Retirement System of Texas trimmed its holdings in shares of McKesson Corporation (NYSE:MCK - Free Report) by 6.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 69,217 shares of the company's stock after selling 4,632 shares during the period. Employees Retirement System of Texas owned 0.06% of McKesson worth $53,473,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. J.W. Cole Advisors Inc. boosted its position in McKesson by 35.3% during the 3rd quarter. J.W. Cole Advisors Inc. now owns 5,089 shares of the company's stock valued at $3,931,000 after purchasing an additional 1,329 shares during the period. Private Wealth Partners LLC grew its stake in McKesson by 5.6% during the 3rd quarter. Private Wealth Partners LLC now owns 31,841 shares of the company's stock worth $24,598,000 after buying an additional 1,682 shares during the last quarter. AlphaQuest LLC increased its position in McKesson by 91.2% in the third quarter. AlphaQuest LLC now owns 1,767 shares of the company's stock worth $1,365,000 after buying an additional 843 shares during the period. CW Advisors LLC lifted its stake in McKesson by 282.5% in the second quarter. CW Advisors LLC now owns 11,008 shares of the company's stock valued at $8,067,000 after buying an additional 8,130 shares during the last quarter. Finally, Envestnet Asset Management Inc. lifted its stake in McKesson by 12.4% in the third quarter. Envestnet Asset Management Inc. now owns 330,647 shares of the company's stock valued at $255,438,000 after buying an additional 36,451 shares during the last quarter. 85.07% of the stock is currently owned by institutional investors.

McKesson Trading Up 1.0%

Shares of NYSE:MCK opened at $943.88 on Friday. The company has a 50 day moving average of $891.54 and a 200-day moving average of $822.52. The firm has a market cap of $115.62 billion, a P/E ratio of 27.15, a P/E/G ratio of 1.50 and a beta of 0.38. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same quarter last year, the business earned $8.03 earnings per share. The business's revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities research analysts forecast that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson's payout ratio is currently 9.43%.

Insider Buying and Selling

In related news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares of the company's stock, valued at $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business's stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 3,868 shares of company stock worth $3,743,820. 0.08% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

MCK has been the subject of several recent research reports. Zacks Research lowered shares of McKesson from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, November 25th. Evercore reiterated an "outperform" rating on shares of McKesson in a research report on Thursday, March 5th. Robert W. Baird set a $968.00 target price on shares of McKesson in a research note on Wednesday, January 14th. Mizuho upped their target price on shares of McKesson from $880.00 to $885.00 and gave the stock a "neutral" rating in a research report on Thursday, February 5th. Finally, Leerink Partners restated an "outperform" rating and issued a $1,085.00 price target on shares of McKesson in a research note on Thursday, March 5th. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $960.93.

McKesson Company Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.